348 related articles for article (PubMed ID: 31488371)
1. Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study.
Bauer A; Klemm M; Rizas KD; Hamm W; von Stülpnagel L; Dommasch M; Steger A; Lubinski A; Flevari P; Harden M; Friede T; Kääb S; Merkely B; Sticherling C; Willems R; Huikuri H; Malik M; Schmidt G; Zabel M;
Lancet; 2019 Oct; 394(10206):1344-1351. PubMed ID: 31488371
[TBL] [Abstract][Full Text] [Related]
2. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study.
Zabel M; Willems R; Lubinski A; Bauer A; Brugada J; Conen D; Flevari P; Hasenfuß G; Svetlosak M; Huikuri HV; Malik M; Pavlović N; Schmidt G; Sritharan R; Schlögl S; Szavits-Nossan J; Traykov V; Tuinenburg AE; Willich SN; Harden M; Friede T; Svendsen JH; Sticherling C; Merkely B;
Eur Heart J; 2020 Sep; 41(36):3437-3447. PubMed ID: 32372094
[TBL] [Abstract][Full Text] [Related]
3. Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH Substudy.
Boas R; Sappler N; von Stülpnagel L; Klemm M; Dixen U; Thune JJ; Pehrson S; Køber L; Nielsen JC; Videbæk L; Haarbo J; Korup E; Bruun NE; Brandes A; Eiskjær H; Thøgersen AM; Philbert BT; Svendsen JH; Tfelt-Hansen J; Bauer A; Rizas KD
Circulation; 2022 Mar; 145(10):754-764. PubMed ID: 34889650
[TBL] [Abstract][Full Text] [Related]
4. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
Stavrakis S; Asad Z; Reynolds D
J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104
[TBL] [Abstract][Full Text] [Related]
5. Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.
El Moheb M; Nicolas J; Khamis AM; Iskandarani G; Akl EA; Refaat M
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012738. PubMed ID: 30537022
[TBL] [Abstract][Full Text] [Related]
6. Nocturnal respiratory rate predicts ICD benefit: A prospective, controlled, multicentre cohort study.
Dommasch M; Steger A; Barthel P; Huster KM; Müller A; Sinnecker D; Laugwitz KL; Penzel T; Lubinski A; Flevari P; Harden M; Friede T; Kääb S; Merkely B; Sticherling C; Willems R; Huikuri HV; Bauer A; Malik M; Zabel M; Schmidt G;
EClinicalMedicine; 2021 Jan; 31():100695. PubMed ID: 33554086
[TBL] [Abstract][Full Text] [Related]
7. Lack of Prognostic Value of T-Wave Alternans for Implantable Cardioverter-Defibrillator Benefit in Primary Prevention.
Pelli A; Kenttä TV; Junttila MJ; Huber C; Schlögl S; Zabel M; Malik M; Willems R; Vos MA; Harden M; Friede T; Sticherling C; Huikuri HV;
J Am Heart Assoc; 2024 Jun; 13(11):e032465. PubMed ID: 38804218
[TBL] [Abstract][Full Text] [Related]
8. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
[TBL] [Abstract][Full Text] [Related]
9. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
[TBL] [Abstract][Full Text] [Related]
10. Myocardial scar burden predicts survival benefit with implantable cardioverter defibrillator implantation in patients with severe ischaemic cardiomyopathy: influence of gender.
Kwon DH; Hachamovitch R; Adeniyi A; Nutter B; Popovic ZB; Wilkoff BL; Desai MY; Flamm SD; Marwick T
Heart; 2014 Feb; 100(3):206-13. PubMed ID: 24186562
[TBL] [Abstract][Full Text] [Related]
11. Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project.
Zabel M; Schlögl S; Lubinski A; Svendsen JH; Bauer A; Arbelo E; Brusich S; Conen D; Cygankiewicz I; Dommasch M; Flevari P; Galuszka J; Hansen J; Hasenfuß G; Hatala R; Huikuri HV; Kenttä T; Kucejko T; Haarmann H; Harden M; Iovev S; Kääb S; Kaliska G; Katsimardos A; Kasprzak JD; Qavoq D; Lüthje L; Malik M; Novotný T; Pavlović N; Perge P; Röver C; Schmidt G; Shalganov T; Sritharan R; Svetlosak M; Sallo Z; Szavits-Nossan J; Traykov V; Vandenberk B; Velchev V; Vos MA; Willich SN; Friede T; Willems R; Merkely B; Sticherling C;
J Electrocardiol; 2019; 57S():S34-S39. PubMed ID: 31526572
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design of the EU-CERT-ICD prospective study: comparative effectiveness of prophylactic ICD implantation.
Zabel M; Sticherling C; Willems R; Lubinski A; Bauer A; Bergau L; Braunschweig F; Brugada J; Brusich S; Conen D; Cygankiewicz I; Flevari P; Taborsky M; Hansen J; Hasenfuß G; Hatala R; Huikuri HV; Iovev S; Kääb S; Kaliska G; Kasprzak JD; Lüthje L; Malik M; Novotny T; Pavlović N; Schmidt G; Shalganov T; Sritharan R; Schlögl S; Szavits Nossan J; Traykov V; Tuinenburg AE; Velchev V; Vos MA; Willich SN; Friede T; Svendsen JH; Merkely B;
ESC Heart Fail; 2019 Feb; 6(1):182-193. PubMed ID: 30299600
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.
Fröhlich GM; Holzmeister J; Hübler M; Hübler S; Wolfrum M; Enseleit F; Seifert B; Hürlimann D; Lehmkuhl HB; Noll G; Steffel J; Falk V; Lüscher TF; Hetzer R; Ruschitzka F
Heart; 2013 Aug; 99(16):1158-65. PubMed ID: 23813845
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of prospective randomized clinical trials.
Romero J; Díaz JC; Grushko M; Quispe R; Briceno D; Avendano R; Golive A; Pina I; Natale A; Garcia MJ; Jorde UP; Di Biase L
Europace; 2018 Sep; 20(FI2):f211-f216. PubMed ID: 29161424
[TBL] [Abstract][Full Text] [Related]
15. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention.
Chan PS; Nallamothu BK; Spertus JA; Masoudi FA; Bartone C; Kereiakes DJ; Chow T
Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):16-24. PubMed ID: 20031808
[TBL] [Abstract][Full Text] [Related]
16. The gender-paradox among patients with implantable cardioverter-defibrillators: a propensity-matched study.
Bhavnani SP; Pavuluri V; Coleman CI; Guertin D; Yarlagadda RK; Clyne CA; Kluger J
Pacing Clin Electrophysiol; 2013 Jul; 36(7):878-84. PubMed ID: 23614760
[TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis.
Akel T; Lafferty J
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28129469
[TBL] [Abstract][Full Text] [Related]
18. Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion.
Žižek D; Mrak M; Jan M; Zupan Mežnar A; Ivanovski M; Žlahtič T; Kajdič N; Antolič B; Klemen L; Skale R; Avramovič Gregorič J; Štublar J; Pernat A; Šinkovec M
Europace; 2024 May; 26(5):. PubMed ID: 38657209
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients.
Jukema JW; Timal RJ; Rotmans JI; Hensen LCR; Buiten MS; de Bie MK; Putter H; Zwinderman AH; van Erven L; Krol-van Straaten MJ; Hommes N; Gabreëls B; van Dorp W; van Dam B; Herzog CA; Schalij MJ; Rabelink TJ;
Circulation; 2019 Jun; 139(23):2628-2638. PubMed ID: 30882234
[TBL] [Abstract][Full Text] [Related]
20. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
